Saturday 17 October 2026
Export LIANY’s income statement to Excel — free account
LianBio Sponsored ADR
LIANY Healthcare Biotechnology
0.05
0.00
0.00%
Follow LIANY
LianBio Sponsored ADR (LIANY) P/E ratio
As of 16 October 2026, LianBio Sponsored ADR (LIANY) trades at a P/E ratio of 0.0×. Over the past ten years it has ranged from 0.0× (December 2023) to 1.7× (March 2024); the current reading is higher than 50% of that period. That is below the Biotechnology industry median of 8.5× and below the Healthcare sector median of 23.0×.
P/E ratio, daily
Embed this chart
Annual newest first
| Period | P/E ratio | Change |
|---|
Against its own ten years
Low 0.0×
High 1.7×
Ten-year median
0.0×
Current reading's percentile
50
P/E ratio against peers
| Company | P/E ratio |
|---|---|
| IRLA Quince Therapeutics, Inc. compare | n/m |
| CRVO CervoMed Inc. compare | n/m |
| ALGS Aligos Therapeutics, Inc. compare | n/m |
| NNVC NanoViricides, Inc. compare | n/m |
| EDSA Edesa Biotech, Inc. compare | n/m |
| LIANY LianBio Sponsored ADR | 0.0× |
| BCTX BRIACELL THERAP compare | 1.5× |
| ATNM Actinium Pharmaceuticals, Inc. compare | 3.1× |
| GNTA Genenta Science S.p.A. Unsponsored ADR compare | — |
| Biotechnology industry median | 8.5× |
| Healthcare sector median | 23.0× |
| Market median | 18.1× |
What P/E ratio is
Price to Earnings Ratio shows how much investors pay for each dollar of a company’s annual profit per share.
Stock Price ÷ EPS (Basic) (TTM)